Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats

The bronchoconstrictor response to adenosine in the actively sensitised Brown Norway rat is markedly augmented following low level allergen (ovalbumin) challenge. The response reflects activation of the A 2B receptor subtype and is mediated by 5-hydroxytryptamine (5-HT) released as a consequence of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2000-10, Vol.406 (3), p.469-476
Hauptverfasser: Tigani, Bruno, Hannon, Jason P, Mazzoni, Lazzaro, Fozard, John R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 476
container_issue 3
container_start_page 469
container_title European journal of pharmacology
container_volume 406
creator Tigani, Bruno
Hannon, Jason P
Mazzoni, Lazzaro
Fozard, John R
description The bronchoconstrictor response to adenosine in the actively sensitised Brown Norway rat is markedly augmented following low level allergen (ovalbumin) challenge. The response reflects activation of the A 2B receptor subtype and is mediated by 5-hydroxytryptamine (5-HT) released as a consequence of mast cell activation. We describe here the effects of wortmannin, a potent inhibitor of phosphatidylinositol-3-kinase and mast cell exocytosis, on the response to adenosine. Bronchoconstrictor responses to adenosine elicited 3 h following ovalbumin challenge were markedly and dose-dependently reduced by wortmannin given intratracheally (i.t.), 1 h prior to or 2 h post-allergen challenge. Responses to methacholine, which activates bronchial smooth muscle directly, and 5-HT were also reduced following wortmannin but to a lesser extent than those to adenosine. Bronchoconstrictor responses to adenosine 3 h post-challenge with vehicle were also markedly reduced by wortmannin given intratracheally (i.t.), 1 h prior to the “sham” challenge. Plasma histamine and 5-HT levels increased in response to adenosine given 3 h following ovalbumin challenge. The increases were suppressed by wortmannin given i.t., 2 h post-ovalbumin challenge. A reduction in the sensitivity of the airways to 5-HT explains in part the reduced bronchoconstrictor response to adenosine induced by wortmannin. A direct action to suppress 5-HT release from airway mast cells induced by adenosine also contributes to the reduction in the response. Inhibition of phosphatidylinositol-3-kinase is the presumed mechanistic basis for the observed effects.
doi_str_mv 10.1016/S0014-2999(00)00705-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72350811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299900007056</els_id><sourcerecordid>72350811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-a2956956fc1159187648810e282601025d8380b0b945f4398734f2554bf375f53</originalsourceid><addsrcrecordid>eNqFkcGKFDEQQIMo7uzqJyg5iOihtZJ0ujsn0WVXhUUP6jmk0xWM9iRjKrPD_L09O4N7FAqKgldVySvGngl4I0B0b78BiLaRxphXAK8BetBN94CtxNCbBnohH7LVP-SMnRP9AgBtpH7MzoSAFpTWK_b7KgT0lXgOfJdLXbuUYuI58bHk5H9mnxPVEn3NhRekzVIi8Zq5mzBlign5wjtf4y3Oe06YKNZIOPEPJe8S_5LLzu15cZWesEfBzYRPT_mC_bi--n75qbn5-vHz5fubxisDtXHS6G6J4IXQZvlP1w6DAJSD7ECA1NOgBhhhNK0OrTJDr9ogtW7HoHodtLpgL49zNyX_2SJVu47kcZ5dwrwl20ulYRBiAfUR9CUTFQx2U-Lalb0VYA-W7Z1le1BoAeydZdstfc9PC7bjGqf7rpPWBXhxAhx5N4fiko90z2klTHfA3h0xXGzcRiyWfMTkcYplOYqdcvzPS_4CzY2Y4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72350811</pqid></control><display><type>article</type><title>Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tigani, Bruno ; Hannon, Jason P ; Mazzoni, Lazzaro ; Fozard, John R</creator><creatorcontrib>Tigani, Bruno ; Hannon, Jason P ; Mazzoni, Lazzaro ; Fozard, John R</creatorcontrib><description>The bronchoconstrictor response to adenosine in the actively sensitised Brown Norway rat is markedly augmented following low level allergen (ovalbumin) challenge. The response reflects activation of the A 2B receptor subtype and is mediated by 5-hydroxytryptamine (5-HT) released as a consequence of mast cell activation. We describe here the effects of wortmannin, a potent inhibitor of phosphatidylinositol-3-kinase and mast cell exocytosis, on the response to adenosine. Bronchoconstrictor responses to adenosine elicited 3 h following ovalbumin challenge were markedly and dose-dependently reduced by wortmannin given intratracheally (i.t.), 1 h prior to or 2 h post-allergen challenge. Responses to methacholine, which activates bronchial smooth muscle directly, and 5-HT were also reduced following wortmannin but to a lesser extent than those to adenosine. Bronchoconstrictor responses to adenosine 3 h post-challenge with vehicle were also markedly reduced by wortmannin given intratracheally (i.t.), 1 h prior to the “sham” challenge. Plasma histamine and 5-HT levels increased in response to adenosine given 3 h following ovalbumin challenge. The increases were suppressed by wortmannin given i.t., 2 h post-ovalbumin challenge. A reduction in the sensitivity of the airways to 5-HT explains in part the reduced bronchoconstrictor response to adenosine induced by wortmannin. A direct action to suppress 5-HT release from airway mast cells induced by adenosine also contributes to the reduction in the response. Inhibition of phosphatidylinositol-3-kinase is the presumed mechanistic basis for the observed effects.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/S0014-2999(00)00705-6</identifier><identifier>PMID: 11040355</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>5-HT ; Active sensitisation ; Adenosine ; Adenosine - pharmacology ; Androstadienes - pharmacology ; Animals ; Biological and medical sciences ; Bronchi - drug effects ; Bronchi - physiology ; Bronchoconstriction ; Brown Norway ; Chronic obstructive pulmonary disease, asthma ; Enzyme Inhibitors - pharmacology ; Histamine - blood ; Male ; Medical sciences ; Methacholine ; Methacholine Chloride - pharmacology ; Ovalbumin ; Ovalbumin - immunology ; Pharmacology. Drug treatments ; Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors ; Phosphatidylinositol-3-kinase ; Pneumology ; rat ; Rats ; Rats, Inbred BN ; Respiratory system ; Serotonin - blood ; Serotonin - pharmacology ; Wortmannin</subject><ispartof>European journal of pharmacology, 2000-10, Vol.406 (3), p.469-476</ispartof><rights>2000 Elsevier Science B.V.</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-a2956956fc1159187648810e282601025d8380b0b945f4398734f2554bf375f53</citedby><cites>FETCH-LOGICAL-c390t-a2956956fc1159187648810e282601025d8380b0b945f4398734f2554bf375f53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014299900007056$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1531965$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11040355$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tigani, Bruno</creatorcontrib><creatorcontrib>Hannon, Jason P</creatorcontrib><creatorcontrib>Mazzoni, Lazzaro</creatorcontrib><creatorcontrib>Fozard, John R</creatorcontrib><title>Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>The bronchoconstrictor response to adenosine in the actively sensitised Brown Norway rat is markedly augmented following low level allergen (ovalbumin) challenge. The response reflects activation of the A 2B receptor subtype and is mediated by 5-hydroxytryptamine (5-HT) released as a consequence of mast cell activation. We describe here the effects of wortmannin, a potent inhibitor of phosphatidylinositol-3-kinase and mast cell exocytosis, on the response to adenosine. Bronchoconstrictor responses to adenosine elicited 3 h following ovalbumin challenge were markedly and dose-dependently reduced by wortmannin given intratracheally (i.t.), 1 h prior to or 2 h post-allergen challenge. Responses to methacholine, which activates bronchial smooth muscle directly, and 5-HT were also reduced following wortmannin but to a lesser extent than those to adenosine. Bronchoconstrictor responses to adenosine 3 h post-challenge with vehicle were also markedly reduced by wortmannin given intratracheally (i.t.), 1 h prior to the “sham” challenge. Plasma histamine and 5-HT levels increased in response to adenosine given 3 h following ovalbumin challenge. The increases were suppressed by wortmannin given i.t., 2 h post-ovalbumin challenge. A reduction in the sensitivity of the airways to 5-HT explains in part the reduced bronchoconstrictor response to adenosine induced by wortmannin. A direct action to suppress 5-HT release from airway mast cells induced by adenosine also contributes to the reduction in the response. Inhibition of phosphatidylinositol-3-kinase is the presumed mechanistic basis for the observed effects.</description><subject>5-HT</subject><subject>Active sensitisation</subject><subject>Adenosine</subject><subject>Adenosine - pharmacology</subject><subject>Androstadienes - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bronchi - drug effects</subject><subject>Bronchi - physiology</subject><subject>Bronchoconstriction</subject><subject>Brown Norway</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Histamine - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methacholine</subject><subject>Methacholine Chloride - pharmacology</subject><subject>Ovalbumin</subject><subject>Ovalbumin - immunology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors</subject><subject>Phosphatidylinositol-3-kinase</subject><subject>Pneumology</subject><subject>rat</subject><subject>Rats</subject><subject>Rats, Inbred BN</subject><subject>Respiratory system</subject><subject>Serotonin - blood</subject><subject>Serotonin - pharmacology</subject><subject>Wortmannin</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcGKFDEQQIMo7uzqJyg5iOihtZJ0ujsn0WVXhUUP6jmk0xWM9iRjKrPD_L09O4N7FAqKgldVySvGngl4I0B0b78BiLaRxphXAK8BetBN94CtxNCbBnohH7LVP-SMnRP9AgBtpH7MzoSAFpTWK_b7KgT0lXgOfJdLXbuUYuI58bHk5H9mnxPVEn3NhRekzVIi8Zq5mzBlign5wjtf4y3Oe06YKNZIOPEPJe8S_5LLzu15cZWesEfBzYRPT_mC_bi--n75qbn5-vHz5fubxisDtXHS6G6J4IXQZvlP1w6DAJSD7ECA1NOgBhhhNK0OrTJDr9ogtW7HoHodtLpgL49zNyX_2SJVu47kcZ5dwrwl20ulYRBiAfUR9CUTFQx2U-Lalb0VYA-W7Z1le1BoAeydZdstfc9PC7bjGqf7rpPWBXhxAhx5N4fiko90z2klTHfA3h0xXGzcRiyWfMTkcYplOYqdcvzPS_4CzY2Y4w</recordid><startdate>20001020</startdate><enddate>20001020</enddate><creator>Tigani, Bruno</creator><creator>Hannon, Jason P</creator><creator>Mazzoni, Lazzaro</creator><creator>Fozard, John R</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001020</creationdate><title>Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats</title><author>Tigani, Bruno ; Hannon, Jason P ; Mazzoni, Lazzaro ; Fozard, John R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-a2956956fc1159187648810e282601025d8380b0b945f4398734f2554bf375f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>5-HT</topic><topic>Active sensitisation</topic><topic>Adenosine</topic><topic>Adenosine - pharmacology</topic><topic>Androstadienes - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bronchi - drug effects</topic><topic>Bronchi - physiology</topic><topic>Bronchoconstriction</topic><topic>Brown Norway</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Histamine - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methacholine</topic><topic>Methacholine Chloride - pharmacology</topic><topic>Ovalbumin</topic><topic>Ovalbumin - immunology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors</topic><topic>Phosphatidylinositol-3-kinase</topic><topic>Pneumology</topic><topic>rat</topic><topic>Rats</topic><topic>Rats, Inbred BN</topic><topic>Respiratory system</topic><topic>Serotonin - blood</topic><topic>Serotonin - pharmacology</topic><topic>Wortmannin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tigani, Bruno</creatorcontrib><creatorcontrib>Hannon, Jason P</creatorcontrib><creatorcontrib>Mazzoni, Lazzaro</creatorcontrib><creatorcontrib>Fozard, John R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tigani, Bruno</au><au>Hannon, Jason P</au><au>Mazzoni, Lazzaro</au><au>Fozard, John R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2000-10-20</date><risdate>2000</risdate><volume>406</volume><issue>3</issue><spage>469</spage><epage>476</epage><pages>469-476</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>The bronchoconstrictor response to adenosine in the actively sensitised Brown Norway rat is markedly augmented following low level allergen (ovalbumin) challenge. The response reflects activation of the A 2B receptor subtype and is mediated by 5-hydroxytryptamine (5-HT) released as a consequence of mast cell activation. We describe here the effects of wortmannin, a potent inhibitor of phosphatidylinositol-3-kinase and mast cell exocytosis, on the response to adenosine. Bronchoconstrictor responses to adenosine elicited 3 h following ovalbumin challenge were markedly and dose-dependently reduced by wortmannin given intratracheally (i.t.), 1 h prior to or 2 h post-allergen challenge. Responses to methacholine, which activates bronchial smooth muscle directly, and 5-HT were also reduced following wortmannin but to a lesser extent than those to adenosine. Bronchoconstrictor responses to adenosine 3 h post-challenge with vehicle were also markedly reduced by wortmannin given intratracheally (i.t.), 1 h prior to the “sham” challenge. Plasma histamine and 5-HT levels increased in response to adenosine given 3 h following ovalbumin challenge. The increases were suppressed by wortmannin given i.t., 2 h post-ovalbumin challenge. A reduction in the sensitivity of the airways to 5-HT explains in part the reduced bronchoconstrictor response to adenosine induced by wortmannin. A direct action to suppress 5-HT release from airway mast cells induced by adenosine also contributes to the reduction in the response. Inhibition of phosphatidylinositol-3-kinase is the presumed mechanistic basis for the observed effects.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>11040355</pmid><doi>10.1016/S0014-2999(00)00705-6</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2000-10, Vol.406 (3), p.469-476
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_72350811
source MEDLINE; Elsevier ScienceDirect Journals
subjects 5-HT
Active sensitisation
Adenosine
Adenosine - pharmacology
Androstadienes - pharmacology
Animals
Biological and medical sciences
Bronchi - drug effects
Bronchi - physiology
Bronchoconstriction
Brown Norway
Chronic obstructive pulmonary disease, asthma
Enzyme Inhibitors - pharmacology
Histamine - blood
Male
Medical sciences
Methacholine
Methacholine Chloride - pharmacology
Ovalbumin
Ovalbumin - immunology
Pharmacology. Drug treatments
Phosphatidylinositol 3-Kinases - antagonists & inhibitors
Phosphatidylinositol-3-kinase
Pneumology
rat
Rats
Rats, Inbred BN
Respiratory system
Serotonin - blood
Serotonin - pharmacology
Wortmannin
title Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T06%3A03%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20wortmannin%20on%20bronchoconstrictor%20responses%20to%20adenosine%20in%20actively%20sensitised%20Brown%20Norway%20rats&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Tigani,%20Bruno&rft.date=2000-10-20&rft.volume=406&rft.issue=3&rft.spage=469&rft.epage=476&rft.pages=469-476&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/S0014-2999(00)00705-6&rft_dat=%3Cproquest_cross%3E72350811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72350811&rft_id=info:pmid/11040355&rft_els_id=S0014299900007056&rfr_iscdi=true